NCT05955872View on ClinicalTrials.gov

A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147

PHASE1CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

July 19, 2023

Primary Completion Date

September 2, 2023

Study Completion Date

September 2, 2023

Conditions

Focal Segmental Glomerulosclerosis (FSGS)

Interventions

DRUG

VX-147

Tablets for oral administration.

Trial Locations (1)

84124

ICON Salt Lake City, Salt Lake City

All Listed Sponsors

lead

Vertex Pharmaceuticals Incorporated

INDUSTRY